Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Impax Laboratories Inc (NASDAQ: IPXL) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Impax Laboratories Inc (NASDAQ: IPXL) concerning whether a series of statements by Impax Laboratories Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On November 3, 2016, Bloomberg News reported that the Justice Department is doing an antitrust investigation of over a dozen companies, including Impax, to find out whether they unlawfully conspired with each other to fix generic drug prices.

Following this news, NASDAQ: IPXL fell $4.00, or 19.51%, to close at $16.50 on November 3, 2016.

Based in Hayward, CA, and founded in 1993 Impax Laboratories Inc is a specialty pharmaceutical company, developing, manufacturing, and marketing bioequivalent pharmaceutical products.

If you purchased shares of Impax Laboratories Inc (NASDAQ: IPXL) on or before November 3, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185